Falchi, L., Baron, J. M., Orlikowski, C. A., & Ferrajoli, A. BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. PAGEPress Publications.
Chicago Style (17th ed.) CitationFalchi, Lorenzo, Jessica M. Baron, Carrie Anne Orlikowski, and Alessandra Ferrajoli. BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. PAGEPress Publications.
MLA (9th ed.) CitationFalchi, Lorenzo, et al. BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. PAGEPress Publications.
Warning: These citations may not always be 100% accurate.